Steven M. Klosk
Independent DirectorMr. Steven M. Klosk, BS, JD, also known as Steve, served as Independent Director of Bolt Projects Holdings, Inc. from August 13, 2024. Mr. Klosk serves as Member of Advisory Board of Phlow Corp. since February 2023. He serves as Director at BioIVT since October 05, 2021. He served as Director at BioVectra Inc. since October 2021 until September 2024. He serves as an Operating Advisor at Linden LLC. He serves as Independent Director at Golden Arrow Merger Corp. since March 16, 2021. He served as Director at NJ BIO, Inc. from March 2021 to December 2024. He served as Director at Recipharm AB (publ) since March 2021 until 2024. He serves as an Independent Director of Lisata Therapeutics, Inc. (formerly known as Caladrius Biosciences, Inc.) since July 8, 2014. Mr. Klosk served as Chief Executive Officer at Cambrex Corporation since May 14, 2008 until June 30, 2020 and served as its President. He is a senior executive with extensive management experience in the life sciences industry. Mr. Klosk served as an Executive Vice President of Cambrex Corp. from February 09, 2007 to May 2008 and Chief Operating Officer since February 09, 2007. He served as President and Chief Executive Officer from May 2008 through June 2020. Mr. Klosk served as the Chief Operating Officer of Cambrex Pharma and Biopharmaceutical Business Unit of Cambrex since October 2003 TO 2007 and served as its Executive Vice President of Administration since October 1996 until 2005, where he led the turnaround of the Biopharma business and significantly increased the custom development activities within the Pharma business. Mr. Klosk served as the President of Pharmaceutical Products & Services of Cambrex Corp. Between 2005 and 2007, Mr. Klosk assumed direct responsibility for the BioPharmaceutical Business Unit of Cambrex and served as its Chief Operating Officer. He joined Cambrex in October 1992 and served as its Vice President of Administration. From February 1988 to October 1992, Mr. Klosk served as Vice President of Administration and Corporate Secretary of The Genlyte Group Inc. He served as Vice President of Administration of Lightolier Inc. from 1985 to 1988. Mr. Klosk served as Director of Cambrex Corporation since May 2008 through December 2019. He serves on the Board of BioVT since October 5, 2021. Mr. Klosk holds a Bachelor of Science degree in Industrial & Labor Relations and Labor Economics from Cornell University in 1979 and a JD degree in Law from New York Law School in 1987.
Positions
- Company NameLisata Therapeutics, Inc.Stock CodeLSTAPositionIndependent DirectorColleagues
- DJDavid J. MazzoCEO & Director
- GBGregory Bailey BrownIndependent Chairman of the Board
- JNJames NiscoSVP of Finance and Treasury & Chief Accounting Officer
- JLJoshua Lehrer-GraiwerPresident & COO
- TITariq ImamHead of Human Resources, Senior VP of Business Development & Operations and General Counsel
- HHHeidi HensonIndependent Director
- CLCynthia Louise FlowersIndependent Director
